Neuro-Ophthalmology News

The American Heart Association issued a scientific statement with recommendations for the diagnosis, treatment and secondary prevention of central retinal artery occlusion, or CRAO.

Patients with Parkinson’s disease and visual dysfunction had a higher risk for cognitive impairment and greater white matter degeneration compared with those without visual dysfunction, according to results published in Movement Disorders.

Asymptomatic brain lesions were rarely observed on conventional MRI in patients with clinically stable, antibody-seropositive neuromyelitis optica spectrum disorder, according to study results of nearly 300 patients.

The FDA granted orphan drug designation to AMX0035, an investigational neuroprotective therapy, for Wolfram syndrome, a rare neurodegenerative disease that causes severe neurological disabilities and results in premature death.

Patients with idiopathic Parkinson’s disease who had lower retinal thickness at baseline demonstrated an increased risk for cognitive decline after 3 years, suggesting layer thickness could have predictive value.

Clinicians may refer suspicious glaucoma diagnoses to neuro-ophthalmologists, according to a presentation at the virtual Women in Ophthalmology Summer Symposium.

Enspryng lowered relapse severity in patients with neuromyelitis optica spectrum disorder, according to data from the double-masked periods of the SAkura phase 3 studies presented at the MSVirtual2020 meeting.

Identifying asymptomatic optic nerve lesions in clinically isolated syndrome requires a lower intereye retinal thickness difference threshold than previously reported, according to findings published in Neurology.

Optical coherence tomography angiography can play “a pivotal role” in managing neurodegenerative disorders, though larger studies are needed to optimize its use for this purpose, according to findings published in Eye and Brain.

The FDA has approved Enspryng for adults with anti-aquaporin-4 antibody positive neuromyelitis optica spectrum disorder, according to a Genentech press release.